A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial - Test2 - elhamkhani - TriplyDB

A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial

A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial

http://www.wikidata.org/entity/Q34571072

about

Nasal delivery of an adenovirus-based vaccine bypasses pre-existing immunity to the vaccine carrier and improves the immune response in mice Animal models for Ebola and Marburg virus infections Current ebola vaccines Ebola Vaccination: If Not Now, When?Ebolavirus vaccines for humans and apes Clinical development of Ebola vaccines Ebola Virus Disease (The Killer Virus): Another Threat to Humans and Bioterrorism: Brief Review and Recent Updates Ebola virus vaccines: an overview of current approaches Mouse models for filovirus infections Dengue E Protein Domain III-Based DNA Immunisation Induces Strong Antibody Responses to All Four Viral Serotypes A West Nile Virus DNA Vaccine Induces Neutralizing Antibody in Healthy Adults during a Phase 1 Clinical Trial A review of Phase I trials of Ebola virus vaccines: what can we learn from the race to develop novel vaccines?Global research trends of World Health Organization's top eight emerging pathogens.Ebola and Marburg virus vaccines.A Perspective on the Development of Plant-Made Vaccines in the Fight against Ebola Virus Plasmid DNA-based vaccines protect mice and ferrets against lethal challenge with A/Vietnam/1203/04 (H5N1) influenza virus.Phase 1 study of pandemic H1 DNA vaccine in healthy adults Prospects for control of emerging infectious diseases with plasmid DNA vaccines.A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses.Demonstration of cross-protective vaccine immunity against an emerging pathogenic Ebolavirus Species Expression of an immunogenic Ebola immune complex in Nicotiana benthamiana.Towards broad protection against Ebolaviruses.Construction of recombinant attenuated Salmonella typhimurium DNA vaccine expressing H pylori ureB and IL-2 Ethics review of studies during public health emergencies - the experience of the WHO ethics review committee during the Ebola virus disease epidemic.Influenza virus h5 DNA vaccination is immunogenic by intramuscular and intradermal routes in humans.Vaccines. An Ebola whole-virus vaccine is protective in nonhuman primates Ebola hemorrhagic fever: current outbreak and progress in finding a cure.DNA vaccines for biodefense.DNA vaccine delivered by a needle-free injection device improves potency of priming for antibody and CD8+ T-cell responses after rAd5 boost in a randomized clinical trial A West Nile virus DNA vaccine utilizing a modified promoter induces neutralizing antibody in younger and older healthy adults in a phase I clinical trial.Toxoplasma gondii protein disulfide isomerase (TgPDI) is a novel vaccine candidate against toxoplasmosis Tackling Ebola: new insights into prophylactic and therapeutic intervention strategies.Filovirus emergence and vaccine development: a perspective for health care practitioners in travel medicine Safety and immunogenicity of DNA vaccines encoding Ebolavirus and Marburgvirus wild-type glycoproteins in a phase I clinical trial Functional genomics reveals the induction of inflammatory response and metalloproteinase gene expression during lethal Ebola virus infection.Immunomodulator-based enhancement of anti smallpox immune responses.Filovirus vaccines.Hegemonic structure of basic, clinical and patented knowledge on Ebola research: a US army reductionist initiative.Harnessing case isolation and ring vaccination to control Ebola.Circulating CXCR5⁺CD4⁺ T Follicular-Like Helper Cell and Memory B Cell Responses to Human Papillomavirus Vaccines

P2860

Q21092172-A221B8C9-98DF-47D6-9FD7-EC01D8AF412E Q21131118-CB47E82E-FDFF-4496-B167-BE0540A48BAA Q21534720-74639AD7-DD92-437A-B103-962F7A241E93 Q22305299-86E305C2-55F8-4C88-9159-056BE7FE86C8 Q24631696-17723CCE-9161-4C8A-99BD-701BAF7C706E Q26775792-EAB0E4C7-CF70-4284-9C5F-A3002DCADEEF Q26798860-2F0C661D-4078-4E54-939F-3D37CD163AC1 Q26999232-B78E72D5-A297-41CD-AE4E-D0EC08B4B8AE Q27011569-1A700B5A-8F5B-4C71-B609-8C6A28A61B9F Q27304342-E5F0CF3D-5635-4BC0-A959-29EBD84F591D Q27488963-8EE04BAE-6759-4D37-A4DB-CF3ECD6178BE Q29994671-1CC4F4DA-652E-4147-9BA3-C1B2F5C6A635 Q30151375-0E96B426-10E9-40F3-912B-2F4B9798B3FD Q30234637-44D0956D-539A-4E5C-ABB7-1D667CE6E7FE Q30235073-9F8DE83F-81EF-4DD1-8E90-2F80D994CFE0 Q30369679-01577866-910F-41CF-87C2-AA929A79C8DA Q30373824-2864E6BF-7657-4064-9F98-E7D5B8D15BC5 Q30380454-A2C45A03-3F69-416C-84BE-22FFF16502E2 Q30398406-6FCC3A15-9ABE-41DB-B641-49951FE19D91 Q33587515-C35808BD-80DA-496E-832D-932D9782567D Q33619065-D1612928-8EC7-4CF3-9F19-1EE6F3BB31CD Q33745567-7907E0DF-E765-489B-B279-E689298177E3 Q33787778-0C6B728E-A85F-47B2-937A-24BBDCEBB221 Q33837161-256036C8-143B-4F80-B6C9-837EECBBC27F Q34407701-4CB29205-C509-4FE2-9B47-53A7FB9A65DD Q34468847-22F7DDE1-EA48-4669-A107-6945EF2AED16 Q34491250-BFEA91A9-2931-488B-8210-D483113F56EC Q34614260-90A30DBF-4654-4029-AA9A-618832E22CEE Q34663554-DA07B0D2-CE17-428B-9D6B-E6715D126979 Q34833926-CDA2AD13-9DB1-40B7-8A32-350FA57EE800 Q34963118-94419570-5C5B-4BD3-AA24-3CB4E82B2320 Q34971349-96AAE4CB-6C32-4871-9100-49416AB1A699 Q35048254-AF482428-ACA0-462C-AC0C-912AF7DDEE7F Q35055198-6CA18D0C-7513-425D-8C9A-E708DF5E9B7C Q35193052-E15C99EA-5863-4CD6-B126-41D36AD3171B Q35391402-797A2E00-44C6-461B-8E25-B613FBC7A961 Q35558539-D548ED0C-6C53-48C5-BF28-BA05866D8393 Q35595035-D243C140-D512-4DA3-BA59-AFD88121EA17 Q35646387-103E77FF-215C-4746-979E-82794E4E4B3A Q35762614-C9983D1A-10E8-42C6-8972-B311BC59501B

P2860

A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial

http://www.wikidata.org/entity/Q34571072

description

2006 nî lūn-bûn

@nan

2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial

@ast

A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial

@en

A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial

@nl

type

label

A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial

@ast

A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial

@en

A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial

@nl

prefLabel

A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial

@ast

A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial

@en

A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial

@nl

P1433

Q34571072-F1F58836-5B14-4E24-8C81-352AD9656EE6

P1476

Q34571072-A40D2421-BEBD-4D35-A867-23C257A933CE

P2093

Q34571072-2C3B38FB-EF44-47BD-AA71-E5437FDF7BE6

Q34571072-2DBF8E09-43C9-4D1E-9E19-0DBC98303C23

Q34571072-2FD1EC4A-5149-4E12-B6C7-2BE0F8603896

Q34571072-31F527A1-A663-4E58-BBD3-160F3267CF19

Q34571072-4800F67D-1101-40A1-9318-0993B1F5FEBE

Q34571072-5847CA24-DC8A-4825-8E5A-37EB0BDD8474

Q34571072-5A5AFF51-F363-4BD5-B48C-AE9FC6FC1255

Q34571072-5E1D49E1-00A7-489E-9362-5A38BDD2A561

Q34571072-7A1C71F0-E6BF-45B9-BEED-CA4184FD26FD

Q34571072-7EC28DAE-A850-46D3-A15F-7B83F63A4654

P2860

Q34571072-0E8B9268-E883-485F-99A3-F389F914D39E

Q34571072-11160778-2948-4299-9756-0F0CF5E68CC8

Q34571072-12D28BFD-179D-448B-80E0-D317E69763CB

Q34571072-14D1BFED-AF68-41A9-9362-1AA3BA54E3F8

Q34571072-1CFBA51F-00D9-47EB-8041-24618EE553C4

Q34571072-213E7BDF-23C7-4D7D-869B-93595F8D0184

Q34571072-24191078-678E-4BAC-B551-B7E2E3C9B80A

Q34571072-26881A86-FEC2-4A79-A9D4-4849C5D6F50F

Q34571072-2F3A618E-EA92-42C4-B9A7-642A085C8377

Q34571072-382044DA-0090-49BA-8F7B-4FDD5D4E8ABD

P304

Q34571072-463A9CA6-17BB-44A4-B6F8-19A49E08AA42

P31

Q34571072-DBD458F5-052E-4552-AC38-BC17E80626A3

P356

Q34571072-B77D1AD2-8B9E-464F-9B15-553E6A123BD0

P433

Q34571072-BA1444B6-E198-4650-8ACE-55F6649549D8

P478

Q34571072-B1BFCCF2-79F1-4A01-BC3F-0C1AE31B9D54

P50

Q34571072-2F5E3223-F99C-480A-904F-F92D2C4860ED

Q34571072-D08DEAFC-DBC7-4A07-8CF5-CDB2EBF52A39

P577

Q34571072-53692D76-D5F2-4CD7-81B9-AA31F7774093

P5875

Q34571072-A4254F30-F3CE-4840-A46D-76D1CF24FCED

P698

Q34571072-28FEF722-9BA1-4CA2-8810-C49840C373F7

P921

Q34571072-206D059D-7165-488A-B2CF-0F2DEF2004C2

Q34571072-6BE28B87-CC23-4DAD-80DF-3DC8955B026B

Q34571072-F58F778B-7FE6-4B8F-B4BA-07ACDE030EF5

P932

Q34571072-65CD64EC-5338-4278-81C1-066E9336FF31

P356

P1433

Clinical and Vaccine Immunology

P1476

A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial

@en

P2093

Bimal K Chakrabarti

http://www.w3.org/2001/XMLSchema#string

Charla A Andrews

http://www.w3.org/2001/XMLSchema#string

Ingelise J Gordon

http://www.w3.org/2001/XMLSchema#string

Judith A Stein

http://www.w3.org/2001/XMLSchema#string

Julie E Martin

http://www.w3.org/2001/XMLSchema#string

Lin Gu

http://www.w3.org/2001/XMLSchema#string

Mario Roederer

http://www.w3.org/2001/XMLSchema#string

Mary E Enama

http://www.w3.org/2001/XMLSchema#string

Michael A Bailey

http://www.w3.org/2001/XMLSchema#string

Nancy J Sullivan

http://www.w3.org/2001/XMLSchema#string

P2860

Development of a preventive vaccine for Ebola virus infection in primates

Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications

Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs

Fruit bats as reservoirs of Ebola virus

Boosting of DNA vaccine-elicited gamma interferon responses in humans by exposure to malaria parasites.

A human T-cell leukemia virus type 1 regulatory element enhances the immunogenicity of human immunodeficiency virus type 1 DNA vaccines in mice and nonhuman primates

Induction of CD4(+) T cell-dependent CD8(+) type 1 responses in humans by a malaria DNA vaccine.

Ebola virus pathogenesis: implications for vaccines and therapies.

Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses.

Immunization for Ebola virus infection.

P304

1267-1277

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/CVI.00162-06

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Barney S. Graham

P577

2006-09-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6806433

http://www.w3.org/2001/XMLSchema#string

P698

16988008

http://www.w3.org/2001/XMLSchema#string

P921

Vaccine against Ebola

phase I clinical trial

P932

1656552

http://www.w3.org/2001/XMLSchema#string